The 16th Frontiers in Cancer Science conference in Singapore includes a thematic focus on immuno-oncology, genomics, metabolism, and AI.
By Bob Riter, Patient Advocate, Cornell Community Cancer Partnership When I was diagnosed with stage 2 breast cancer about...
By Ross Uhrich, DMD, MBA, ARPA-H Program Manager for POSEIDON and NITRO programs, Health Science Futures Mission Office What...
Bianca Islam, MD, PhD, examines how social determinants of health impact cancer patients and what is being done to...
by Ashok Venkitaraman, MBBS, PhD Singapore will hold its 15th Frontiers in Cancer Science (FCS) conference November 6-8 at...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
Guest post by Keith Hornberger, PhD The AACR-Chemistry in Cancer Research (CICR) Working Group’s mission is to advocate the...
Guest post by Jennifer J. Gao, Patricia Keegan, Paul G. Kluetz, and Richard Pazdur Editor’s note: The authors all...